How Can We Help?
You are here:
< Back

βk-5-MAPB is an entactogenic drug which is both a substituted cathinone and substituted benzofuran, being structurally related to methylone and 5-MAPB. It acts as a monoamine releaser with selectivity for serotonin and has a similar potency to MDMA.[1][2][3]

References

  1. ^ WO 2021/252538, Baggott M, "Advantageous benzofuran compositions for mental disorders or enhancement", published 16 December 2021, assigned to Tactogen Inc. 
  2. ^ WO 2023/107653, Baggott MJ, Lofthus SJ, De Leona XM, Singh A, Hudgins CJ, "Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement", published 21 September 2023, assigned to Tactogen Inc. 
  3. ^ WO 2023/107715, Baggott M, Dalziel S, "Specialized combinations for mental disorders or mental enhancement", published 15 June 2023, assigned to Tactogen Inc. 
Categories
Table of Contents